Interaction between the Product of the Breast Cancer Susceptibility Gene BRCA2 and DSS1, a Protein Functionally Conserved from Yeast to Mammals

ABSTRACT Germ line mutations in the breast cancer susceptibility geneBRCA2 predispose to early-onset breast cancer, but the function of the nuclear protein encoded by the gene is ill defined. Using the yeast two-hybrid system with fragments of humanBRCA2, we identified an interaction with the humanDSS1 (deleted in split hand/split foot) gene. Yeast and mammalian two-hybrid assays showed that DSS1 can associate with BRCA2 in the region of amino acids 2472 to 2957 in the C terminus of the protein. Using coimmunoprecipitation of epitope-taggedBRCA2 and DSS1 cDNA constructs transiently expressed in COS cells, we were able to demonstrate an association. Furthermore, endogenous BRCA2 could be coimmunoprecipitated with endogenous DSS1 in MCF7 cells, demonstrating an in vivo association. Apparent orthologues of the mammalianDSS1 gene were identified in the genome of the yeastsSchizosaccharomyces pombe and Saccharomyces cerevisiae. Yeast strains in which these DSS1-like genes were deleted showed a temperature-sensitive growth phenotype, which was analyzed by flow cytometry. This provides evidence for a link between the BRCA2 tumor suppressor gene and a gene required for completion of the cell cycle.

[1]  V. Olkkonen,et al.  SEM1, a homologue of the split hand/split foot malformation candidate gene Dss1, regulates exocytosis and pseudohyphal differentiation in yeast. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Sigurdsson,et al.  High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation. , 1998, Cancer research.

[3]  F. Couch,et al.  Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. , 1998, Molecular cell.

[4]  P. Hasty,et al.  Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence. , 1998, Cancer research.

[5]  E. Reddy,et al.  The BRCA2 is a histone acetyltransferase , 1998, Oncogene.

[6]  B. Ponder,et al.  Thymic lymphomas in mice with a truncating mutation in Brca2. , 1998, Cancer research.

[7]  J. Eyfjörd,et al.  BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. , 1998, Cancer research.

[8]  B. Ponder,et al.  Involvement of Brca2 in DNA repair. , 1998, Molecular cell.

[9]  A. Ashworth,et al.  Functions of the BRCA1 and BRCA2 genes. , 1998, Current opinion in genetics & development.

[10]  P. Bartel,et al.  RAD51 Interacts with the Evolutionarily Conserved BRC Motifs in the Human Breast Cancer Susceptibility Gene brca2 * , 1997, The Journal of Biological Chemistry.

[11]  A. Ashworth,et al.  Nuclear location and cell cycle regulation of the BRCA2 protein. , 1997, Cancer research.

[12]  A. Ashworth,et al.  Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation , 1997, Nature Genetics.

[13]  J. Eyfjörd,et al.  BRCA2 mutation in Icelandic prostate cancer patients , 1997, Journal of Molecular Medicine.

[14]  F. Alt,et al.  RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Mak,et al.  Brca2 is required for embryonic cellular proliferation in the mouse. , 1997, Genes & development.

[16]  T. Ludwig,et al.  Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. , 1997, Genes & development.

[17]  Luke Hughes-Davies,et al.  Transcriptional activation functions in BRCA2 , 1997, Nature.

[18]  G. Eichele,et al.  Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.

[19]  H. Gardner,et al.  Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. , 1997, Developmental biology.

[20]  A. Ashworth,et al.  Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. , 1997, Human molecular genetics.

[21]  Yonghong Xiao,et al.  Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.

[22]  M. Stratton,et al.  A polymorphic stop codon in BRCA2 , 1996, Nature Genetics.

[23]  A. Scarpa,et al.  Chromosome 7q allelic losses in pancreatic carcinoma. , 1996, Cancer research.

[24]  B. Trask,et al.  Split hand/split foot malformation, deafness, and mental retardation with a complex cytogenetic rearrangement involving 7q21.3. , 1996, Journal of medical genetics.

[25]  Yusuke Nakamura,et al.  Mutation analysis in the BRCA2 gene in primary breast cancers , 1996, Nature Genetics.

[26]  M. Skolnick,et al.  Low incidence of BRCA2 mutations in breast carcinoma and other cancers , 1996, Nature Genetics.

[27]  S. Scherer,et al.  Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. , 1996, Human molecular genetics.

[28]  J. Rommens,et al.  BRCA2 germline mutations in male breast cancer cases and breast cancer families , 1996, Nature Genetics.

[29]  Kenneth Offit,et al.  Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer , 1996, Nature Genetics.

[30]  J. Eyfjörd,et al.  A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes , 1996, Nature Genetics.

[31]  P. Bork,et al.  Internal repeats in the BRCA2 protein sequence , 1996, Nature Genetics.

[32]  J. Rommens,et al.  The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.

[33]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[34]  J. Gudmundsson,et al.  Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. , 1995, Cancer research.

[35]  C. Marshall,et al.  Ras recruits Raf‐1 to the plasma membrane for activation by tyrosine phosphorylation. , 1995, The EMBO journal.

[36]  D. Easton,et al.  Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. , 1995, Oncogene.

[37]  S. Scherer,et al.  Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1. , 1994, American journal of human genetics.

[38]  M. D'Esposito,et al.  Cloning and characterization of two members of the vertebrate Dlx gene family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[40]  C. Marshall,et al.  A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. , 1993, The Journal of biological chemistry.

[41]  E. Winter,et al.  An osmosensing signal transduction pathway in yeast. , 1993, Science.

[42]  K. Maundrell,et al.  TATA box mutations in the Schizosaccharomyces pombe nmt1 promoter affect transcription efficiency but not the transcription start point or thiamine repressibility. , 1993, Gene.

[43]  A. Shinohara,et al.  Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein , 1992, Cell.

[44]  K. Gould,et al.  Phosphorylation at Thr167 is required for Schizosaccharomyces pombe p34cdc2 function. , 1991, The EMBO journal.

[45]  G K Lewis,et al.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product , 1985, Molecular and cellular biology.

[46]  S. Seal,et al.  Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene , 1997, Nature Genetics.

[47]  A. Ashworth,et al.  The BRC repeats are conserved in mammalian BRCA2 proteins. , 1997, Human molecular genetics.

[48]  A. Sigurdsson,et al.  Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables. , 1997, Anticancer research.

[49]  C. Larsson,et al.  Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families , 1996, Nature Genetics.

[50]  S. Moreno,et al.  Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. , 1991, Methods in enzymology.

[51]  R. Rothstein.  One-step gene disruption in yeast. , 1983, Methods in enzymology.